Tiffany Wang

机构：University of California, Los Angeles · ORCID：0000-0001-6444-4020

发表论文 69 篇 · 总被引 1493 次 · h-index 20

代表论文

• The global landscape of approved antibody therapies (2022 · Antibody Therapeutics · 被引 177)
• First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study (2021 · European Journal of Cancer · 被引 56)
• Colorectal cancer screening in the COVID-19 era (2021 · World Journal of Gastrointestinal Oncology · 被引 51)
• Delirium prediction in the ICU: designing a screening tool for preventive interventions (2022 · JAMIA Open · 被引 31)
• Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients (2021 · Journal of Clinical Microbiology · 被引 25)
• Incidence of Hypertensive Disorders of Pregnancy in Women with COVID-19 (2021 · American Journal of Perinatology · 被引 21)